[go: up one dir, main page]

NO840244L - Fremgangsmaate for fremstilling av aminerte derivater av pyridazin. - Google Patents

Fremgangsmaate for fremstilling av aminerte derivater av pyridazin.

Info

Publication number
NO840244L
NO840244L NO840244A NO840244A NO840244L NO 840244 L NO840244 L NO 840244L NO 840244 A NO840244 A NO 840244A NO 840244 A NO840244 A NO 840244A NO 840244 L NO840244 L NO 840244L
Authority
NO
Norway
Prior art keywords
pyridazine
thienyl
methyl
formula
amine
Prior art date
Application number
NO840244A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Paul Kan
Kathleen Biziere
Camille-Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO840244L publication Critical patent/NO840244L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO840244A 1983-01-24 1984-01-23 Fremgangsmaate for fremstilling av aminerte derivater av pyridazin. NO840244L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301029A FR2539742B1 (fr) 1983-01-24 1983-01-24 Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central

Publications (1)

Publication Number Publication Date
NO840244L true NO840244L (no) 1984-07-25

Family

ID=9285222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840244A NO840244L (no) 1983-01-24 1984-01-23 Fremgangsmaate for fremstilling av aminerte derivater av pyridazin.

Country Status (24)

Country Link
US (1) US4524070A (fi)
EP (1) EP0117171B1 (fi)
JP (1) JPS59139367A (fi)
KR (1) KR910000641B1 (fi)
AT (1) ATE28077T1 (fi)
AU (1) AU560542B2 (fi)
CA (1) CA1218063A (fi)
CS (1) CS241539B2 (fi)
DD (1) DD238793A5 (fi)
DE (1) DE3464491D1 (fi)
DK (1) DK31584A (fi)
ES (1) ES529007A0 (fi)
FI (1) FI840268A (fi)
FR (1) FR2539742B1 (fi)
GR (1) GR81717B (fi)
HU (1) HU192390B (fi)
IE (1) IE840150L (fi)
IL (1) IL70757A (fi)
NO (1) NO840244L (fi)
NZ (1) NZ206907A (fi)
PT (1) PT77982B (fi)
SU (1) SU1189345A3 (fi)
YU (1) YU12384A (fi)
ZA (1) ZA84501B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02504523A (ja) * 1987-08-19 1990-12-20 エルヴェーエー―エントゾルグング・アクチエンゲゼルシャフト 廃油の浄化および再生法
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
PT93060B (pt) 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
CN1984904A (zh) * 2004-05-08 2007-06-20 神经能质公司 3-芳基-5,6-二取代哒嗪

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292443A (en) * 1968-11-01 1972-10-11 Ct D Etudes Experimentales Et New pyridazine derivatives and process for their preparation
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives

Also Published As

Publication number Publication date
CA1218063A (en) 1987-02-17
IE840150L (en) 1984-07-24
DD238793A5 (de) 1986-09-03
DE3464491D1 (en) 1987-08-06
ZA84501B (en) 1984-09-26
PT77982B (fr) 1986-04-10
KR840007409A (ko) 1984-12-07
CS241539B2 (en) 1986-03-13
ATE28077T1 (de) 1987-07-15
GR81717B (fi) 1984-12-12
ES8407043A1 (es) 1984-09-01
EP0117171B1 (fr) 1987-07-01
FR2539742A1 (fr) 1984-07-27
IL70757A0 (en) 1984-04-30
FI840268A0 (fi) 1984-01-23
KR910000641B1 (ko) 1991-01-31
FR2539742B1 (fr) 1986-09-05
FI840268A (fi) 1984-07-25
AU560542B2 (en) 1987-04-09
HU192390B (en) 1987-06-29
EP0117171A1 (fr) 1984-08-29
CS53084A2 (en) 1985-07-16
NZ206907A (en) 1987-03-31
DK31584D0 (da) 1984-01-24
DK31584A (da) 1984-07-25
IL70757A (en) 1986-12-31
PT77982A (fr) 1984-02-01
ES529007A0 (es) 1984-09-01
US4524070A (en) 1985-06-18
YU12384A (en) 1986-10-31
JPS59139367A (ja) 1984-08-10
SU1189345A3 (ru) 1985-10-30
AU2372784A (en) 1984-07-26

Similar Documents

Publication Publication Date Title
SU1442077A3 (ru) Способ получени замещенных андроста-1,4-диен-3,17-дионов
EP0820441B1 (en) INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
Ferrarini et al. Synthesis and β-blocking activity of (R, S)-(E)-oximeethers of 2, 3-dihydro-1, 8-naphthyridine and 2, 3-dihydrothiopyrano [2, 3-b] pyridine: potential antihypertensive agents–Part IX
TW413679B (en) Lactam derivatives useful as psychotherapeutic agents and pharmaceutical compositions containing them
CN102388048B (zh) 三唑并[4,3-b]哒嗪衍生物及其用于前列腺癌的用途
NO174051B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolyl-, triazolyl- og pyrazolylforbindelser
MX2008001020A (es) Un monohidrato de pirrolo[1-2-b]pirazol piridin quinolin substituido como inhibidor de factor de crecimiento de transformacion-beta (tgf-beta).
NO310072B1 (no) Pyrimidinderivater som 5HT2C-reseptor antagonister
CN101848909A (zh) 可用作蛋白激酶抑制剂的吡咯并[3,2-c]吡啶
RU2007393C1 (ru) Способ получения тетрагидробенз (c,d)индоловых агонистов серотонина
NO159272B (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive dihydropyridiner.
NO840244L (no) Fremgangsmaate for fremstilling av aminerte derivater av pyridazin.
JPH06511483A (ja) インドール類
JPH09511238A (ja) α−拮抗活性を有するキナゾリニル−アミノ誘導体
NO159170B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazin-forbindelser.
KR100355170B1 (ko) 20위치에아미노치환사슬이있는신규한스테로이드,그의제조방법및중간체,의약의로서의용도,및그를함유하는조성물
NO148673B (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
DK162050B (da) Pyrazolderivater med ergolinskelet eller salte deraf, deres fremstilling, farmaceutiske praeparater indeholdende disse og fremgangsmaade til fremstilling af de farmaceutiske praeparater
US4104385A (en) Cyclic alkylidenyl N-[6-(amino)-3-pyridazinyl]aminomethylenemalonates
KR20090008261A (ko) 가용성 아데닐레이트 시클라제 억제제
JP7289017B2 (ja) ピロリジニルウレア誘導体の結晶及びその使用
WO1999021831A1 (en) Tricyclic compounds as cgmp-pde inhibitors
NO822565L (no) 2-cyanosteroider.
KR20090007351A (ko) 가용성 아데닐레이트 시클라제 억제제
WO2025011479A1 (en) Pyrazole based inhibitors of LDH and their use in immune and inflammatory diseases